Senores Pharmaceuticals to hold investor conference on June 12

0 min read     Updated on 10 Jun 2026, 04:49 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Senores Pharmaceuticals announced a virtual investor conference on June 12, 2026, hosted by Choice Broking. The meeting will cover company performance based on public information without sharing UPSI. The schedule is subject to change due to exigencies.

powered bylight_fuzz_icon
42532639

*this image is generated using AI for illustrative purposes only.

Senores Pharmaceuticals has announced a virtual investor conference scheduled for June 12, 2026, to engage with analysts and institutional investors. The meeting aims to discuss the company's performance and outlook based on publicly available information, ensuring no unpublished price sensitive information (UPSI) is shared during the interaction.

The session is scheduled to take place between 03:00 P.M. (IST) and 04:00 P.M. (IST). Choice Broking will host the group meeting, which will be conducted virtually. The company noted that the schedule remains subject to change due to exigencies on the part of the host or the company.

Meeting Details

Date & Time Hosted by Nature of Meeting Mode of Meeting
12 June, 2026
03:00 P.M. (IST) to
04:00 P.M. (IST)
Choice Broking Group Meeting Virtual

The disclosure was made pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Vinay Kumar Mishra, Company Secretary and Compliance Officer, signed the intimation on June 09, 2026.

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+11.14%+23.52%+34.68%+68.93%+137.96%+131.58%

What key performance metrics is Senores Pharmaceuticals likely to emphasize during the conference?

How might the investor conference influence market sentiment and stock performance in the short term?

What strategic initiatives or growth drivers could the company outline for the post-2026 period?

Senores Pharmaceuticals
View Company Insights
View All News
like19
dislike

Senores Pharmaceuticals schedules analyst meet on June 9

0 min read     Updated on 05 Jun 2026, 02:25 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Senores Pharmaceuticals has scheduled an analyst and institutional investor meeting on June 9, 2026, hosted by Macquarie in Mumbai. The physical group meeting will be held from 1:30 PM to 2:30 PM IST, complying with SEBI Regulation 30(6).

powered bylight_fuzz_icon
42114267

*this image is generated using AI for illustrative purposes only.

Senores Pharmaceuticals has scheduled an analyst and institutional investor meeting on June 9, 2026. The meeting is intended to engage with market analysts and institutional investors to discuss the company's performance and outlook.

The session will be hosted by Macquarie and will take place in Mumbai. It is scheduled as a physical group meeting, providing a platform for direct interaction between the company's management and investors.

The meeting is set to occur from 1:30 PM to 2:30 PM IST. This initiative follows the disclosure requirements under Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (SEBI) regulations.

Meeting Details

Date & Time Host Nature of Meeting Place Mode
June 9, 2026
01:30 PM to 02:30 PM IST
Macquarie Group Meeting Mumbai Physical

Historical Stock Returns for Senores Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+11.14%+23.52%+34.68%+68.93%+137.96%+131.58%

What key strategic initiatives or growth drivers is Senores Pharmaceuticals likely to highlight during the meeting?

How might the outcomes of this meeting influence investor sentiment and the company's stock performance in the near term?

What are the potential market implications of Macquarie hosting the meeting, given their role as a financial intermediary?

Senores Pharmaceuticals
View Company Insights
View All News
like15
dislike

More News on Senores Pharmaceuticals

1 Year Returns:+137.96%